Leica Biosystems PD-L1 BOND antibody

Wednesday, 05 December, 2018 | Supplied by: Leica Microsystems Pty Ltd



Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.

The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.

Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.

Online: www.leica-microsystems.com
Phone: 1800 625 286
Related Products

BioLamina Biosilk biomaterial for 3D cell culture of hPSCs

BioLamina's Biosilk is a 3D cell culture biomaterial made from recombinant spider silk...

Matreya natural, synthetic and bacterial-derived phospholipids

Phospholipids are well known for their role as the main component of membranes, where they form...

AdipoGen Life Sciences Interleukin-33 research products

AdipoGen Life Sciences offers a broad range of Interleukin-33 research solutions, including an...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd